CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing healthcare expenditure and growing geriatric population
4.1.2. Increasing adoption of Point-of-Care urinalysis devices and technological advancements
4.1.3. Rising prevalence of kidney diseases and urinary tract infections
4.1.4. Implementation of patient protection and affordable care act in the U.S.
4.2. Market Restraints and Challenges
4.2.1. The lower adoption rate of fully automated urine analysers in developing economies
4.2.2. Stringent regulatory environment and implementation of excise duty on the sale of
medical devices in the developed nations
4.3. Market Opportunities
4.3.1. Portable and battery-operated urinalysis devices via smartphones
4.3.2. Emerging Asian economies to offer growth opportunities
4.3.3. Growing prevalence of sedentary lifestyle in individuals
CHAPTER 5 GLOBAL URINALYSIS MARKET – BY PRODUCT TYPE
5.1. Consumables
5.1.1. Chemical Agents
5.1.2. Reagent Strips
5.1.3. Plastic Consumables
5.2. Instruments
5.2.1. Integrated Chemistry and Sediment Analyzers
5.2.2. Portable Analyzers
5.2.3. Chemistry Analyzers
5.2.4. Microscopy/Sediment Analyzers
5.3. Point-of-Care Devices
5.4. Automated Urine Sediment Analyzers
CHAPTER 6 GLOBAL URINALYSIS MARKET – BY TEST TYPE
6.1. Sediment Urinalysis
6.1.1. Flow Cytometric Urinalysis
6.1.2. Microscopic Urinalysis
6.2. Biochemical Urinalysis
CHAPTER 7 GLOBAL URINALYSIS MARKET – BY APPLICATION
7.1. Pregnancy Tests
7.2. Disease Diagnosis
7.2.1. Diabetes
7.2.2. Liver Diseases
7.2.3. Urinary Tract Infections
7.2.4. Kidney Diseases
7.2.5. Others
7.3. Others
CHAPTER 8 GLOBAL URINALYSIS MARKET – BY END USER
8.1. Research Laboratories and Institutes
8.2. Diagnostic Laboratories
8.3. Home Care Settings
8.4. Hospitals & Clinics
8.5. Others
CHAPTER 9 GLOBAL URINALYSIS MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL URINALYSIS MARKET - COMPANY PROFILES
10.1. Sysmex Corporation
10.2. Arkray, Inc.
10.3. Acon Laboratories, Inc.
10.4. Bio-Rad Laboratories, Inc.
10.5. 77 Elektronika, Ltd.
10.6. Mindray Medical International Ltd.
10.7. URIT Medical Electronic Group Co., Ltd.
10.8. Siemens AG
10.9. F. Hoffmann-LA Roche Ltd.
10.10. Danaher Corporation
CHAPTER 11 GLOBAL URINALYSIS MARKET – COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
